Marco Schito

Title: The Innovative Contributions of Marco Schito

Introduction

Marco Schito is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of anti-retroviral research, particularly in the development of compounds that target retroviruses such as HIV. With a total of 2 patents, his work has the potential to impact the treatment and prevention of viral infections.

Latest Patents

Marco Schito's latest patents focus on acythiols and component thiol compositions as anti-HIV and anti-retroviral agents. These patents describe certain thiol and acylthiol compounds that inhibit retrovirus growth by attacking the highly conserved zinc finger regions of essential viral proteins. The compounds and compositions containing them are detailed for their methods of use in treating retroviral infections like HIV. Additionally, these compounds are useful for the preparation of vaccines comprised of inactivated retroviruses, prevention of transmission, and detection of retroviral proteins.

Career Highlights

Throughout his career, Marco Schito has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to contribute to vital research in the field of infectious diseases.

Collaborations

Marco has collaborated with notable colleagues such as John K Inman and Atul Goel. These partnerships have further enhanced the impact of his research and innovations.

Conclusion

Marco Schito's innovative work in the field of anti-retroviral agents showcases his dedication to advancing medical science. His contributions have the potential to change the landscape of treatment for retroviral infections.